Letermovir T5396
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Letermovir (AIC246) is a novel anti-CMV compound (EC50: about 5 nM in fibroblast cells). It targets the pUL56 subunit of the viral terminase complex.
CAS nr:
917389-32-3
Purity:
98%
Molecular Weight:
572,55
SMILES:
COc1cccc(c1)N1CCN(CC1)C1=Nc2c(F)cccc2[C@H](CC(O)=O)N1c1cc(ccc1OC)C(F)(F)F
Formula:
C29H28F4N4O4
Pathway:
Microbiology/Virology,Proteases/Proteasome,Others
Target:
HCV Protease,HCV Protease,Others
